Brief: Ceapro Inc Enters Into Research Collaboration With Angiogenesis Foundation For Beta Glucan And Avenanthramides
23/08/2021 13:52
Aug 23 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO INC. ENTERS INTO RESEARCH COLLABORATION WITH THE
ANGIOGENESIS FOUNDATION FOR BETA GLUCAN AND AVENANTHRAMIDES
Source text for Eikon: ID:nGNX80lCNl
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases